Seeking Alpha

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to...

Amarin (AMRN) gets FDA approval of Vascepa, formerly known as AMR101, as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Shares are currently halted.
Comments (3)
  • brendoo7
    , contributor
    Comments (8) | Send Message
     
    i am so so hapy.and i hope for all the investor who was belive in this drug
    to have avery good business days.
    27 Jul 2012, 07:15 AM Reply Like
  • Stogiees
    , contributor
    Comments (39) | Send Message
     
    Why is AMRN price dropping?
    27 Jul 2012, 10:52 AM Reply Like
  • mitrado
    , contributor
    Comments (1961) | Send Message
     
    Simple... the market's are rigged to force people lose their money.
    This is exactly why I never bought AMRN over $11. Too much risk.
    27 Jul 2012, 12:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|